We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA: PMRS Oxycodone NDA Did Not Include Enough Data on Abuse-Deterrent Properties
FDA: PMRS Oxycodone NDA Did Not Include Enough Data on Abuse-Deterrent Properties
The FDA declined to approve a Pharmaceutical Manufacturing Research Services NDA for a new oxycodone hydrochloride product due to insufficient evidence of its abuse-deterrent properties, the agency said a Feb. 12 notice.